111 related articles for article (PubMed ID: 26477787)
1. Metabolic profiling of a novel antithrombotic compound, S002-333 and enantiomers: metabolic stability, species comparison and in vitro-in vivo extrapolation.
Saxena A; Valicherla GR; Jain GK; Bhatta RS; Saxena AK; Gayen JR
Biopharm Drug Dispos; 2016 May; 37(4):185-99. PubMed ID: 26477787
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of a novel antithrombotic compound, S002-333, and its enantiomers: quantitative cytochrome P450 phenotyping, metabolic profiling and enzyme kinetic studies.
Saxena A; Jain GK; Siddiqui HH; Bhunia SS; Saxena AK; Gayen JR
Xenobiotica; 2014 Apr; 44(4):295-308. PubMed ID: 23992115
[TBL] [Abstract][Full Text] [Related]
3. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice.
Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS
Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits.
Saxena A; Valicherla GR; Joshi P; Saxena R; Cheruvu SH; Bhunia SS; Jain GK; Siddiqui HH; Saxena AK; Gayen JR
Xenobiotica; 2015; 45(11):1016-23. PubMed ID: 26084373
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective degradation of metalaxyl and its enantiomers in rat and rabbit hepatic microsomes in vitro.
Zhang P; Shen Z; Xu X; Zhu W; Dang Z; Wang X; Liu D; Zhou Z
Xenobiotica; 2012 Jun; 42(6):580-6. PubMed ID: 22348420
[TBL] [Abstract][Full Text] [Related]
7. Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes.
Li S; Teng L; Liu W; Cheng X; Jiang B; Wang Z; Wang C
Drug Test Anal; 2017 May; 9(5):754-768. PubMed ID: 27377954
[TBL] [Abstract][Full Text] [Related]
8. Species differences for stereoselective metabolism of ethofumesate and its enantiomers in vitro.
Zhu W; Dang Z; Qiu J; Liu Y; Lv C; Diao J; Zhou Z
Xenobiotica; 2009 Sep; 39(9):649-55. PubMed ID: 19552529
[TBL] [Abstract][Full Text] [Related]
9. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
Nishimuta H; Houston JB; Galetin A
Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
[TBL] [Abstract][Full Text] [Related]
11. Determination of metabolic profile of novel triethylamine containing thiophene S006-830 in rat, rabbit, dog and human liver microsomes.
Hidau MK; Singh Y; Singh SK
Drug Test Anal; 2016 Feb; 8(2):180-8. PubMed ID: 25921927
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical method development and validation of novel antithrombotic agent S002-333 by LC-MS/MS and its application to pharmacokinetic studies.
Bhatta RS; Kumar D; Chhonker YS; Saxena AK; Jain GK
Biomed Chromatogr; 2010 Nov; 24(11):1234-9. PubMed ID: 20954216
[TBL] [Abstract][Full Text] [Related]
14. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
[TBL] [Abstract][Full Text] [Related]
15. Comparative metabolism of cinobufagin in liver microsomes from mouse, rat, dog, minipig, monkey, and human.
Ma XC; Ning J; Ge GB; Liang SC; Wang XL; Zhang BJ; Huang SS; Li JK; Yang L
Drug Metab Dispos; 2011 Apr; 39(4):675-82. PubMed ID: 21205911
[TBL] [Abstract][Full Text] [Related]
16. In vitro hepatic microsomal metabolism of meloxicam in koalas (Phascolarctos cinereus), brushtail possums (Trichosurus vulpecula), ringtail possums (Pseudocheirus peregrinus), rats (Rattus norvegicus) and dogs (Canis lupus familiaris).
Kimble B; Li KM; Valtchev P; Higgins DP; Krockenberger MB; Govendir M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Apr; 161():7-14. PubMed ID: 24345479
[TBL] [Abstract][Full Text] [Related]
17. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data.
Iwatsubo T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358
[TBL] [Abstract][Full Text] [Related]
18. The metabolism of the 5HT3 antagonists, ondansetron, alosetron and GR87442 II: investigation into the in vitro methods used to predict the in vivo hepatic clearance of ondansetron, alosetron and GR87442 in the rat, dog and human.
Somers GI; Bayliss MK; Houston JB
Xenobiotica; 2007 Aug; 37(8):855-69. PubMed ID: 17701833
[TBL] [Abstract][Full Text] [Related]
19. Comparative metabolism and stability of andrographolide in liver microsomes from humans, dogs and rats using ultra-performance liquid chromatography coupled with triple-quadrupole and Fourier transform ion cyclotron resonance mass spectrometry.
Zhao HY; Hu H; Wang YT
Rapid Commun Mass Spectrom; 2013 Jun; 27(12):1385-92. PubMed ID: 23681817
[TBL] [Abstract][Full Text] [Related]
20. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
